Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 trial of hematopoietic stem cell transplantation for antiphospholipid syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Snippet

Sponsor: Richard Burt, MD | Conditions: ANTIPHOSPHOLIPID SYNDROME | Phase 1 | Status: WITHDRAWN